Delivery Order SPE2DB24D1205-SPE2DB25FCXZT
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $11,396.68 delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, with completion targeted for September 10, 2025. The contract is for the supply of Forteo (teriparatide) 560 micrograms per 2.24 milliliters in pen injection form, a prescription medication used to treat osteoporosis. Awarded as a firm fixed-price, non-set-aside delivery order, this...
- AmerisourceBergen Drug Corp was awarded a delivery order contract on September 18, 2025, valued at $20,560.37 for the supply of Forteo (560 mcg/2.24 mL pen injections) to support the Defense Logistics Agency's Medical Supply Chain. The contract is firm fixed price with no set-aside designation, and performance is scheduled for completion by September 19, 2025, with the place of performance located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a $54,516.23 delivery order contract by the Defense Logistics Agency on July 22, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injections). The contract is set to be completed by July 23, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract worth $6,027.24 for the supply of Forteo 600 mcg/2.4 mL pen injections. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- The Defense Logistics Agency awarded a $7,804.29 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). This contract represents a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. As a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,968.17 on May 27, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). This firm fixed-price delivery order, which completes on May 28, 2025, was competitively awarded without a set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under the company's larger...
- The Defense Logistics Agency awarded a $7,201.22 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections. This firm fixed-price contract, with a completion date of September 2, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award involved no set-aside designation and was competitively awarded....
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, the Corporate Office division of pharmaceutical distributor Amerisourcebergen Corporation. The $3,544.12 firm fixed price contract is for the supply of Forteo 600 mcg/2.4 ml pen injections to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $9,296.70 for Teriparatide 560mcg/2.24ml pens with an ultimate completion date of August 1, 2025. The contract, awarded July 31, 2025, employs firm fixed-price pricing and carries no set-aside designation, indicating competitive award. This delivery order represents a child contract under AmerisourceBergen's larger...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract covers the delivery of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty pharmaceutical product, to support military healthcare programs. The award has a ceiling value of $6,903.90 and a completion date of October 25, 2024. No set-aside...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXZTDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $9,781.40 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on June 24, 2025, for the supply of Forteo 560 MCG/2.24 ML pen injections. The award is a child delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain, supporting military healthcare systems and the Defense Health Agency. The delivery order, with an ultimate completion date of June 25, 2025, is a component of AmerisourceBergen's comprehensive pharmaceutical support vehicle through the DLA. This contract vehicle enables the company to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. The Pharmaceutical Prime Vendor Global Program under DLA Troop Support is structured to involve multiple regional contractors, positioning AmerisourceBergen as a key participant in federal pharmaceutical distribution operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 6/24/25 |